Lifecore Biomedical Overview
Valuation check: LFCR's PEG ratio is 3.19, below the Materials sector average of 10.44.
Get informed when a big investor buys or sells
+ Follow3.19
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
The latest PEG ratio for LFCR is 3.19. That is below the Materials sector average of 10.44. Investors often review this figure alongside Lifecore Biomedical's historical trend and sector peers before judging valuation or financial health.
Against Materials companies, LFCR currently prints 3.19 for PEG ratio, while the sector average sits near 10.44. That is roughly 69.4% below the sector mean. Large gaps often invite a closer look at Lifecore Biomedical's growth, margins, and balance sheet.
A PEG ratio of 3.19 for Lifecore Biomedical is not 'good' or 'bad' on its own. Compare it with the peer average (10.44) and with LFCR's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting LFCR's PEG ratio (3.19), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Lifecore Biomedical's PEG ratio against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.
